Frontiers | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?
John Libbey Eurotext - Hématologie - Loss of CD20 expression on CLL cells following treatment with rituximab
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises | Immunotherapy
Frontiers | Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties | Scientific Reports
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
CD-20 | ドライブレコーダー | セルスター工業株式会社
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives - Kidney International
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
CD antigens expression in B cells
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies | Bentham Science
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
Unraveling the T–B tangle in anti-CD20 multiple sclerosis therapy | PNAS
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients | HTML
Potential anti-CD20 mAb effector mechanisms. (A) Fc-Fc ␥ R–dependent... | Download Scientific Diagram
The applications of anti-CD20 antibodies to treat various B cells disorders - ScienceDirect
Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
Mechanisms of action of anti-CD20 monoclonal antibodies. Abbreviation:... | Download Scientific Diagram
